Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial
- DOI
- 10.1038/s41467-026-72059-7
- Published
- 2026-04-23
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-72059-7,
title = {Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial},
author = {Liying Zhao and Hao Liu and Yanfeng Hu and Jiang Yu and Shuqiang Yuan and Fangqin Xue and Kaihua Huang and Xinhua Chen and Tian Lin and Mingli Zhao and Tao Chen and Lina Yu and Zhao Chen and Xuefeng Zhong and Fengping Li and Chengcai Liang and Hao Chen and Weihong Guo and Huayuan Liang and Guoxin Li},
year = {2026},
journal = {Nature Communications},
doi = {10.1038/s41467-026-72059-7},
url = {https://doi.org/10.1038/s41467-026-72059-7}
}RIS
TY - JOUR TI - Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial AU - Liying Zhao AU - Hao Liu AU - Yanfeng Hu AU - Jiang Yu AU - Shuqiang Yuan AU - Fangqin Xue AU - Kaihua Huang AU - Xinhua Chen AU - Tian Lin AU - Mingli Zhao AU - Tao Chen AU - Lina Yu AU - Zhao Chen AU - Xuefeng Zhong AU - Fengping Li AU - Chengcai Liang AU - Hao Chen AU - Weihong Guo AU - Huayuan Liang AU - Guoxin Li PY - 2026 JO - Nature Communications DO - 10.1038/s41467-026-72059-7 UR - https://doi.org/10.1038/s41467-026-72059-7 ER -
APA
Zhao, L., Liu, H., Hu, Y., Yu, J., Yuan, S., Xue, F., Huang, K., Chen, X., Lin, T., Zhao, M., Chen, T., Yu, L., Chen, Z., Zhong, X., Li, F., Liang, C., Chen, H., Guo, W., Liang, H., & Li, G. (2026). Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial. Nature Communications. https://doi.org/10.1038/s41467-026-72059-7
Source records
- crossref · retrieved 2026-09-25T23:08:01.116Z